Graft-versus-host disease in children after hematopoietic cell transplantation: potential clinical utility of biomarkers

Biomarkers may improve diagnosis and prognosis, monitoring of response to treatment, allowing for treatment that are customized to the patients, and overall leading to reduce healthcare costs. In the near future, biomarkers will be included in all clinical trials and decisions for a personalized medicine. The biomarker field